Stay updated on Teclistamab Combo in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Teclistamab Combo in Multiple Myeloma Clinical Trial page.

Latest updates to the Teclistamab Combo in Multiple Myeloma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision: v3.3.3 was added to the page. The HHS Vulnerability Disclosure link and the Revision: v3.3.2 entry were removed from the footer.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedNew version entry on 2025-12-04 with 56 changes, including updates to the Study Status, in the record history.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page history shows a new revision label v3.3.2 added and the previous v3.2.0 removed, a metadata update to the page's versioning rather than substantive content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedNew history entry added for 2025-11-07; government funding notices were removed on 2025-11-07 and 2025-11-10.SummaryDifference0.4%

- Check55 days agoChange DetectedA new version entry (Version 55) was added on 2025-11-06 and a Study Status update was posted on 2025-11-10; the 2025-10-10 entry was removed.SummaryDifference0.2%

- Check62 days agoChange DetectedVisual updates to the Record History page only, with no changes to trial details, statuses, or version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Teclistamab Combo in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teclistamab Combo in Multiple Myeloma Clinical Trial page.